Abstract
There is a widespread perception amongst patients with osteoarthritis (OA) of the knee that their condition is a 'wear and tear' problem for which no effective treatment is available. The current framework of therapy is a pyramid approach in which additional therapies are introduced as the disease progresses. However, recent increases in our understanding of the pathogenesis of OA have led to a number of exciting clinical trials of potential disease-modifying anti-OA drugs (DMAODs). Further development of these agents will alter our approach to treatment of this all too common problem.
| Original language | English |
|---|---|
| Pages (from-to) | 59-65 |
| Number of pages | 7 |
| Journal | Current Therapeutics |
| Volume | 40 |
| Issue number | 1-2 |
| Publication status | Published - 1 Dec 1999 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver